TSE:MBX Microbix Biosystems (MBX) Stock Price, News & Analysis → Wall Street Icon: 'I'd Put 50% of My Kids' Inheritance in THIS stock' (From Stansberry Research) (Ad) Free MBX Stock Alerts C$0.34 0.00 (0.00%) (As of 06/11/2024 ET) Add Compare Share Share Today's RangeC$0.34▼C$0.3550-Day RangeC$0.32▼C$0.3852-Week RangeC$0.23▼C$0.45Volume62,000 shsAverage Volume68,423 shsMarket CapitalizationC$46.72 millionP/E Ratio11.33Dividend Yield2.30%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Get Microbix Biosystems alerts: Email Address Ad Market Moving TrendsTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Click to View The 5 Best AI Stocks to Invest In About Microbix Biosystems Stock (TSE:MBX)Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.Read More MBX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBX Stock News HeadlinesMay 15, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Reports Strong Results for Q2 Fiscal 2024May 15, 2024 | finance.yahoo.comMicrobix Reports Strong Results for Q2 Fiscal 2024May 15, 2024 | finance.yahoo.comMicrobix Biosystems Up More Than 10% As Q2 Profit Grows On Higher Revenues; Says Stage Set For Record FYMay 15, 2024 | morningstar.comMicrobix Biosystems Inc MBXMay 14, 2024 | uk.finance.yahoo.comMicrobix Biosystems Inc. (MBX.TO)May 8, 2024 | finance.yahoo.comCould The Market Be Wrong About Microbix Biosystems Inc. (TSE:MBX) Given Its Attractive Financial Prospects?May 8, 2024 | finance.yahoo.comMicrobix Schedules Release of Results for Q2 Fiscal 2024April 25, 2024 | markets.businessinsider.comMicrobix Collaborator Introduces New Lab Accreditation ProgramApril 11, 2024 | finance.yahoo.comMicrobix Presenting at the 2024 Bloom Burton ConferenceApril 1, 2024 | finance.yahoo.comMicrobix Announces Annual and Special Meeting Voting ResultsMarch 14, 2024 | finance.yahoo.comMicrobix’s Clot-Buster Drug Project AdvancesMarch 11, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck CancerMarch 11, 2024 | ca.finance.yahoo.comStocks in play: Microbix Biosystems Inc.March 1, 2024 | wsj.comMicrobix Biosystems Inc.February 26, 2024 | finance.yahoo.comMicrobix Announces Issuance of Stock OptionsFebruary 17, 2024 | finance.yahoo.comMicrobix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)February 14, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024February 14, 2024 | finance.yahoo.comMicrobix Reports Record Results for Q1 Fiscal 2024February 7, 2024 | finance.yahoo.comMicrobix Schedules Release of Results for Q1 Fiscal 2024February 6, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease PathogenFebruary 6, 2024 | finance.yahoo.comMicrobix Unveils Test Control for Gastric Ulcer Disease PathogenJanuary 3, 2024 | finance.yahoo.comMicrobix Achieves Further QAPs Sales RecordDecember 22, 2023 | finance.yahoo.comMicrobix Biosystems Full Year 2023 Earnings: Revenues Miss ExpectationsDecember 21, 2023 | finance.yahoo.comMicrobix Reports Results for Q4 & Full-Year Fiscal 2023December 14, 2023 | finance.yahoo.comMicrobix & Seegene USA Jointly Enhancing Lab Test AccuracySee More Headlines Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/12/2024Next Earnings (Estimated)8/08/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:MBX CUSIPN/A CIKN/A Webmicrobix.com Phone+1-905-3618910FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.03 Trailing P/E Ratio11.33 Forward P/E Ratio17.00 P/E GrowthN/ANet IncomeC$3.72 million Net Margins16.57% Pretax MarginN/A Return on Equity14.66% Return on Assets1.87% Debt Debt-to-Equity Ratio24.53 Current Ratio8.53 Quick Ratio5.57 Sales & Book Value Annual SalesC$22.42 million Price / Sales2.08 Cash FlowC$0.08 per share Price / Cash Flow4.13 Book ValueC$0.20 per share Price / Book1.70Miscellaneous Outstanding Shares137,420,000Free FloatN/AMarket CapC$46.72 million OptionableNot Optionable Beta0.25 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Cameron L. GroomePresident, CEO & DirectorMr. James S. CurrieChief Financial OfficerDr. Kenneth Hughes Ph.D.Chief Operating OfficerDr. Mark Luscher Ph.D.Senior Vice President of Scientific AffairsMr. Philip CasselliSenior Vice President of Sales, Business Development & MarketingMr. Christopher B. LobbCompliance Officer, General Counsel & SecretaryMore ExecutivesKey CompetitorsBriaCell TherapeuticsCVE:BCTImmunoPrecise AntibodiesCVE:IPAOncolytics BiotechTSE:ONCScythian BiosciencesCVE:SCYB138267 (COM.TO)TSE:COMView All CompetitorsInsidersBo HollasSold 100,000 sharesTotal: C$39,250.00 ($0.39/share)Steven Trevor HagermanSold 5,500 sharesTotal: C$2,172.50 ($0.40/share)Cameron Lionel GroomeSold 119,500 sharesTotal: C$47,023.25 ($0.39/share)Jennifer Anne StewartBought 13,945 shares on 1/22/2024Total: C$5,996.35 ($0.43/share)View All Insider Transactions MBX Stock Analysis - Frequently Asked Questions Should I buy or sell Microbix Biosystems stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MBX shares. View MBX analyst ratings or view top-rated stocks. How have MBX shares performed in 2024? Microbix Biosystems' stock was trading at C$0.39 at the beginning of the year. Since then, MBX stock has decreased by 12.8% and is now trading at C$0.34. View the best growth stocks for 2024 here. When is Microbix Biosystems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our MBX earnings forecast. What other stocks do shareholders of Microbix Biosystems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB). How do I buy shares of Microbix Biosystems? Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:MBX) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.